Nizatidine Recall Issued As FDA Finds NDMA Contamination In Another Heartburn Drug
A second generic Axid recall has been issued due to high levels of NDMA, a known carcinogen.
Tag Archives: Axid
-
-
Generic Axid Recall Issued Over Presence of Cancer-Causing Chemical NDMA
A generic Axid recall has been issued after the discovery of trace amounts of NDMA in the active ingredient.
-
Zantac Does Not Turn Into NDMA In Stomach, But Levels Exceeding Safety Limits Still Present: FDA
FDA testing does not find that Zantac turns into NDMA in the stomach, but does confirm high enough levels of the carcinogen to justify Zantac recalls.
